Skip to main content
Erschienen in: Supportive Care in Cancer 6/2018

29.08.2017 | Letter to the editor

Bismuth adjuvant and adverse effects of chemotherapy: issues with statistical analyses

verfasst von: Peter Dalgaard, Claus Thorn Ekstrøm, Dorte Kronborg

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor of Supportive Care in Cancer, …
Literatur
1.
Zurück zum Zitat Hansen PB, Penkowa M (2017) Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study. Support Care Cancer 25:1279. https://doi.org/10.1007/s00520-016-3522-6 CrossRefPubMed Hansen PB, Penkowa M (2017) Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study. Support Care Cancer 25:1279. https://​doi.​org/​10.​1007/​s00520-016-3522-6 CrossRefPubMed
2.
Zurück zum Zitat R Core Team (2016). R: a language and environment for statistical computing. Vienna, Austria R Core Team (2016). R: a language and environment for statistical computing. Vienna, Austria
Metadaten
Titel
Bismuth adjuvant and adverse effects of chemotherapy: issues with statistical analyses
verfasst von
Peter Dalgaard
Claus Thorn Ekstrøm
Dorte Kronborg
Publikationsdatum
29.08.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3859-5

Weitere Artikel der Ausgabe 6/2018

Supportive Care in Cancer 6/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.